chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Vaccine recipient was a minor (17 y/o) and was given the  MODERNA Covid-19 vaccine, instead of the PFIZER Covid-19 vaccine. There was a miscommunication and after multiple verbal verifications of age and consent the vaccinator did not confirm the vaccine was PFIZER and instead administered MODERNA. After vaccination, the guardian gave the vaccinator the orange "Pfizer ONLY" paper placard and it was then the vaccinator realized the minor was given the wrong presentation of vaccine. The vaccinator alerted the lead clinician on site, and another individual, spoke with the guardian and explained the medical error that occured and answered any questions or concerns that arose.
p/vax pt exp tiredness; achiness; fever; no treatment given; fever resolved; tiredness; achiness ongoing
onset 2APR96 @ 330AM;fever, chills, t101, stiffness, aching in legs & arms, h/a x 3 days, weak;slowly improved over 4 days;
Two days after vaccination (Feb 10) ,  I developed a very itchy  3 -inch rash and  ~ 2-inch lump that appeared on and below my left jaw line.  The lump was not painful except when I touched it  when washing my face.   On Feb 12th, I started to put Cortaid and neosporin on the area .  The  rash and lump fully resolved by February 16th.   (Please note that the lot # on my vaccination card is not entirely clear-- It could also be 630MZ04.)
I am having Arrhythmia every minute and every day since Aug 9.  I received first dose Aug 2nd and Monday Aug 9 the constant Arrhythmia started. I still had my second dose Aug 23. I went to see primary doctor today  because Arrhythmia has gotten worse and not improving... I had an EKG and MD referred me to see an electrophysiologist to have a Holter monitor.  I don't have an appointment until next Thursday Sept 2. They did not have anything sooner.
This spontaneous report was received from a nurse referring to unspecified patients of unknown age and gender. The patients' medical histories and concurrent conditions were not reported. On unspecified dates since 24-OCT-2015, the patients were vaccinated with doses of oral, ROTATEQ (Lot# K022990; expiration date 26-JUN-2016) (dose was not reported), which were exposed to temperatures outside of the recommended range. Concomitant therapies were not reported. No adverse experiences have been reported. There was no product quality complaint (PQC) involved. This is one of several reports from the same source. Additional information has been requested.
Focal dystonia; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 50-year-old female patient received BNT162b2 (BNT162B2), on 20Oct2021 as dose 2, single (Lot number: FE3590) at the age of 50 years for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Bnt162b2 (dose 1, Lot number: FE3592), for Covid-19 immunization, reaction(s): "very sporadically some pulling in the right side/ focal dystonia". The following information was reported: DYSTONIA (medically significant), outcome "unknown", described as "Focal dystonia". The clinical course was as follows: Patient had the vaccines. It has been about 8 months prior and initially, she felt good but after the first one, she started noticing just very sporadically some pulling in her right side. She didn't relate it to the vaccine initially and then she got the second dose and the pulling started to happen more and more significantly to the point where her entire right side, like she was having pulling in her arm. It was going down her leg and she was having muscle spasms in her right leg, in her right foot where she has actually been to a neurologist. She has gotten 2 MRIs, 2 EEGs. There was nothing there that would indicate why it would be happening. The neurologist basically was diagnosing her with focal dystonia. When she asked him if he think this could be from the vaccine, the neurologist answered he didn't know, as there is no way to know. Since the patient has been to him, the neurologist reached out to her multiple times and he said at least 6 other women, right around her age have been there to see him with identical symptoms, all on one side of their body and all blaming the vaccines. Initially when she first went to the doctor, the doctor thought she was having focal seizures. She did take something for a very short time because it didn't work. The medicine was oxcarbazepine (TRILEPTAL).; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201269543 same patient/event, different dose number;
This spontaneous report as received from an immunization official, refers to an unspecified number of patient of unknown age and gender. The patients' concurrent conditions, medical history and concomitant medications were not mentioned. On unknown dates, the patients were vaccinated with improperly stored doses of VARIVAX of lot # L042264, expiry date: 26-OCT-2017  and lot# M000760, expiry date: 06-JAN-2018 (dose#, site of administration and route not provided). No adverse effect were reported. No additional information was provided. Product quality complaint was not filed. Additional information is not expected as the reported did not wish further contact. This is one of the two reports form the same reporter.
Breakthrough case admission after three vaccines Moderna 3/5/21 LOt# 004M20A;  Moderna 3/9/21 Lot# 012L20A;  Moderna 11/17/21 Lot# 065F  DO NOT REQUEST THE LOT NUMBER;  THIS IS ALL THE INFORMATION IN THE LOCAL DATABASE
The patient had titres drawn on an unspecified date and they were low; This spontaneous report was received from a nurse and refers to a male patient of unknown age. No information was provided regarding the patient's medical history, concurrent conditions, drug reactions, allergies or concomitant medications.  On an unspecified date, the patient was vaccinated with Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) for prophylaxis (strength, dose number, anatomical location, route of administration, lot number and expiration date were not reported).   The patient was working in a place where there was a measles outbreak, consequently a titers were drawn on an unknown date and they were low (viral titre decreased). It was unknown if the patient sought medical attention or if treatment was given for the event.    On an unknown date, the patient was vaccinated again with Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) for low titers (strength, dose number, anatomical location, route of administration, lot number and expiration date were not reported).  At the time of reporting, the outcome of the event and the causal relationship between the event and vaccination with Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) were not reported.
neck and under the arm lymph nodes got swelled up; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 34 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 01May2021 13:15 (Lot number: EN6206) at the age of 34 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "No" (unspecified if ongoing), notes: NO. The patient's concomitant medications were not reported. Past drug history included: No, notes: No. The following information was reported: LYMPHADENOPATHY (non-serious) with onset 2021, outcome "recovering", described as "neck and under the arm lymph nodes got swelled up". The event "neck and under the arm lymph nodes got swelled up" was evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of lymphadenopathy.  Additional information: It was reported that patient was not received any other vaccines within 4 weeks prior to the COVID vaccine. Patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination patient was not tested for COVID-19. Patient was Visited to Physician or Other Health Professional Office for neck and under the arm lymph nodes got swelled up. Patient had had a chest and neck CT scan done.  No follow-up attempts are possible. No further information is expected.
Localized rash at injection site (about 2 inches in diameter, red, hot to touch, slightly itchy, soar); headache for past day and a half, two douses of Tylenol and one excedrine migraine have not helped.
Started with swelling of Rt. lower leg with pain, pain went to Rt. and Lt. side of upper leg, had appointment with Fam. Doctor was sent to get Ultra sound of Rt. upper leg was then advised to go straight to emergency room, started on cores of blood thinners after a blood clot was found.
Extreme pain at injection site lasting over 4 days. Pain started Monday following injection and still painful through Thursday. Pain better with Tylenol and ice, but still arm is hard to move.
got the worst flu / Suspected vaccination failure; got the worst flu; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Flu unspecified (Flu vaccine) for prophylaxis.   On an unknown date, the patient received Flu vaccine. On an unknown date, an unknown time after receiving Flu vaccine, the patient experienced vaccination failure (Verbatim: got the worst flu / Suspected vaccination failure) (serious criteria GSK medically significant) and influenza (Verbatim: got the worst flu). The outcome of the vaccination failure was unknown and the outcome of the influenza was not reported.   It was unknown if the reporter considered the vaccination failure and influenza to be related to Flu vaccine.     It was unknown if the company considered the vaccination failure and influenza to be related to Flu vaccine.   Additional Information: GSK Receipt Date: 09-MAR-2023 This case was reported by a patient via interactive digital media. The reporter stated that only time he/she ever had the flu shot and got the worst flu of his/her life. The reporter further stated that never again. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming influenza were unknown at the time of reporting. The follow up would not possible as no contact details were available.
This case was reported by a other health professional via call center representative and described the occurrence of polyarthritis in a male patient who received ENGERIX B adult for prophylaxis. On 14th February 2019, the patient received ENGERIX B adult. On 16th February 2019, 2 days after receiving ENGERIX B adult, the patient experienced polyarthritis (serious criteria GSK medically significant), fever and flu symptoms. The patient was treated with ibuprofen. On an unknown date, the outcome of the polyarthritis, fever and flu symptoms were recovered/resolved. The reporter considered the polyarthritis and fever to be related to ENGERIX B adult. It was unknown if the reporter considered the flu symptoms to be related to ENGERIX B adult. Additional details were reported as follows: This case was reported by the physician's assistant. The age at vaccination was not reported. On Thursday 3 weeks before the time of reporting, the patient received a dose of ENGERIX B adult. Forty eight hours after vaccination, the patient experienced flu symptoms as low grade fever and polyarthritis for 24 hours. It was returned about 2:00 to 3:00pm every day at night. The only thing that helps was ibuprofen. The patient seen a physician this afternoon to had blood work drawn. The emergency room visit required. The call was transferred to medical information for additional questions. The reporter consented to follow up. This case has been linked with case US2019GSK043898, reported by the same reporter.
Injection site became red, swollen, painful and itchy spreading downward to elbow. Seen in ER 3 days after immunization and diagnosed with cellulitis. Started Rx with Keflex and oral steroid
Moderna vaccine (NDC--80777-0273-99, lot # 048C21A) was received at store on 7/16/2021 and placed under refrigerated temperature.  3 vials were transferred to another store location where 20 doses were administered beyond use date.
fatigue  and chills second day. after 4 days developed full body hives, treating with benadryla dn medrol dose pack
Information has been received from a female patient of unknown age referring to herself. The patient's pertinent medical history, current conditions and concomitant medications were not reported. No previous drug reactions or allergies were reported. The patient received the first dose of RECOMIBVAX HB (dosing details were not reported) on 10-NOV-2014, the second dose on 17-NOV-2017 and the third dose on 01-DEC-2014. No adverse effects were reported. There was no product quality complaint involved. Additional information is not expected, as the reporter did not wish further contact.
PT COMPLAINED OF EXTREME FATIGUE, MUSCLE ACHES, FEVER, NOT BEING ABLE TO LIFT ARM VACCINES WERE GIVEN IN, AND INJECTION SITE REDNESS THAT EXTENDED ALL THE WAY TO HER ELBOW THAT WAS HOT TO TOUCH, THAT STARTED THE DAY AFTER RECEIVING VACCINATIONS WITH NO IMPROVEMENT 4 DAYS LATER. PT HAD TO LEAVE WORK EARLY ON DAY 2 AND CALLED OUT OF WORK ON DAY 3. PT CALLED PCP ON DAY 4, WHO SUSPECTED CELLULITIS AND PT WAS TO MAKE APPOINTMENT ON DAY 5. PT WAS ADVISED ON DAY 4 THAT IF REDNESS SPREAD FURTHER TO GO TO ER.
Chills, headache and arm swollen and red like I was bit by a tick. About 5 cm redness.
This spontaneous report as received from a medical assistant refers to 6 unspecified patients with unknown ages and unknown genders. On unknown dated the patients were vaccinated with PNEUMOVAX23 (route, dose, lot# and expiration date unknown). The medical assistant reported a patient developed fevers, fatigues and the injection sites were red, painful to the touch and swollen after receiving PNEUMOVAX23. The reactions were almost leading to cellulitis in the arm (capture in MARRS# 1311USA004305). The medical assistant also reported that 6 other unspecified patients had the "exact same" reactions after receiving PNEUMOVAX23. The outcome of the events was unknown. This is one of several reports received from the same source. Additional information has been requested.
From initial information received on 4/21/04 from a health care professional regarding an adverse event occurring in the USA, it was reported that a 60 year old female patient received TD ADS ADULT vaccination, lot number U1021AA, administered IM in the left deltoid, and a first dose of ENGERIX B, lot number ENG5465A6, administered IM In the right deltoid on 4/6/04 at 11:00 AM. Four days later, on 4/10/04, the patient experienced urticaria, itching and swelling. She was treated with cortisone pills. The patient has not recovered from this event. From additional information received on 5/21/04, it was initially reported by a nurse that the patient experienced hives all over her body four days following the administration of the products. The patient was seen at a physician's office and treated with Medrol and Prednisone. The event improved, but it was not reported whether the patient recovered. The immunization series with ENGERIX B was discontinued. The nurse considered the hives to be possibly related to vaccination with ENGERIX B and tetanus toxoid. No other information was provided. From additional information received on 8/16/04 from the initial reporter, it was reported that the case was reviewed and there is no additional information available at this time.
Telephone call received from mom that after receiving vaccines child cried for 1-2 days, T-105-rash-chicken pox like. Child continues to have rash. Child to PMD - mom reports, PDM stated child has viral infection along with vaccine reaction. Mom is requesting financial help for MD visits.
About 6 hours later Pt began getting tired, fatigued that escalated into vomiting and unresponsive, non-verbal, confused, delirious, 103 degrees fever, 911 was called pt admitted to ICU.
Pt recv vax on 11/10/98; on 11/11/98 pt exp Rt Arm sore, red, warm; vomited; hives on back; tx=compresses, Tylenol
Fast heart rate, feeling confused, dizzy, shaky, heated. Heart accelerated to 120 within the first 5 minutes of getting the shot.
This spontaneous report as received from a healthcare worker refers to a patient of unknown age and gender. No information regarding the patient's medical history was provided. On 08-APR-2014 the patient was vaccinated with VAQTA dose 2, 0.5 ml, intramuscularly, less than six months after the patient received the first dose (on 18-MAR-2014). No concomitant medication was reported. No adverse effect was reported. No outcome was reported. Additional information has been requested.
Within 2 days of receiving the vaccine I developed an outbreak of shingles on my upper back just below my neck
Pt given Pfizer as second dose.  She received Moderna as first dose on 6-28-21
Patient has a 2.5 inch high x 3 inch long red area that is warm to the touch at site of DTaP shot.  Mom was advised ice, tylenol per mouth by doctor.
Swelling and tenderness around injection site. Approximately 2 1/2"x3 1/2".
a little fever; This is a spontaneous report from a contactable consumer (patient). This is the first case out of 2 cases. A male patient of an unspecified age received BNT162B2 (Pfizer Covid 19 vaccine, Solution for injection, number: Unknown, Expiry date: Unknown) via an unspecified route of administration on 16Jun2021 as single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date in Jun2021, the patient experienced fever. Consumer stated, "both had vaccine yesterday, he was feeling okay, a little fever but was good. He wanted to know whether should wait and drink some water or should go to emergency room and was that normal". Limited information was available over the call. Reporter seriousness was unspecified. Outcome of the event was recovered on an unspecified date in Jun2021.  Information about batch/lot number has been requested.
10/22/11 - Bilateral muscle weakness hands & forearms. During day progressed to include bilateral muscle spasms of calves with pain & weakness. By evening symptoms migrated to hamstrings. 10/23/11 symptoms cont to migrate to upper and lower extremities and started to lose dexterity in fingers. 10/23/11 night - very achy, tired, movement was very difficult, experienced tightness with movement. 10/24/11 at 4AM - woke up due to pain and tightness of thorax and neck. Seen at 8:15AM at PHCP office and sent directly to ER.
This spontaneous prospective pregnancy report has been received from a medical assistant concerning a 26 year old female patient. The patient's medical history, concurrent conditions, concomitant medications and drug reactions/allergies were not provided. On 16-JUL-2007, the patient was vaccinated with the first dose of GARDASIL (dose, strength, route of administration, anatomical location, lot# and expiration date were not provided), for prophylaxis. On an unknown date, the patient was vaccinated with the second dose of GARDASIL (dose, strength, route of administration, anatomical location, lot# and expiration date were not provided), for prophylaxis. On 07-APR-2017, the patient was vaccinated with the third dose of GARDASIL 9, 0.5 ml, one dose, intramuscularly (lot # M035486 with expiration date 05-JUN-2019), for prophylaxis. On 20-APR-2017, the patient contacted her physician, when she learned that she was pregnant. It was determined that the patient was four weeks pregnant at the time of the third vaccination. No adverse effects were reported. The patient's last menstrual period was on 10-MAR-2017 and estimated date of delivery was 15-DEC-2017. Additional information has been requested.
Reported "horrible headaches" started same day, missed work day two! Itching & rash on arm. Pain in arm to neck & back of head.
low fever, rash on face, ears and neck. 2 days later spots on arms and legs - rash still evident  Called doctor several times - who said Chicken Pox vaccine would NOT give this reaction. Prescribed Benadryl and cortisone cream.  (same child got full body measles rash in response to first MMR several years ago)
Parent complains child developed sudden onset of cough/fatigue post vaccination. I am writing to inform you that after receiving the Tdap vaccine on 5th June 2014, patient started a cough. Her cough started on June 6th, the day after the vaccine. Nurse had informed regarding pain or fever but had not mentioned cough as a possible side-effect. The pain in her arm lasted for approx. 3 days but the cough has progressively increased. Last night, she could not sleep due to persistent cough. So at  approx. 1.30 am I called facility phone number to ask what to do. Earlier during the day patient fell asleep in the afternoon while sitting which she has never done before. The doctor on call called back. He said he had not heard of cough after Tdap vaccine. I told the doctor on call that patient did not have a cough prior to the vaccine and that the cough came on suddenly without any symptoms. Patient also did not have a common cold or was not ill prior to the vaccine. So he said to give patient some cough suppressant and warm tea with honey to ease her cough and to watch out for her breathing. We gave patient DELSYM and warm drink. She finally fell asleep. She still has a cough. So I am writing to find out the signs we should be watching over the next few days to ensure she is okay. Also, please report this side-effect to CDC (VAERS). Please let me know what we should be watching out for.
Patient received first dose on 11-Mar-2021 and second dose on 16-Sep-2021; This spontaneous case was reported by a nurse and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received first dose on 11-Mar-2021 and second dose on 16-Sep-2021) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 020F21A and 001B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Mar-2021 at 5:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Sep-2021 at 1:30 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Sep-2021 at 1:30 PM,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received first dose on 11-Mar-2021 and second dose on 16-Sep-2021). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received first dose on 11-Mar-2021 and second dose on 16-Sep-2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications information was not reported. No treatment medications were provided.   This case was linked to MOD-2022-503779 (Patient Link).